enVVeno Medical

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$0
$812
$0
Gross Profit
-130
-122
406
-129
EBITDA
-6,564
-4,832
-6,577
-6,041
EBIT
-6,694
-4,954
-6,699
-6,170
Net Income
-6,694
-4,503
-6,229
-5,642
Net Change In Cash
0
0
812
0
Free Cash Flow
-4,940
-4,018
-5,109
-4,285
Cash
2,044
2,937
1,754
17,915
Basic Shares
20,352
20,352
20,379
16,067

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-528
-546
-525
-452
EBITDA
-21,291
-25,018
-24,144
-16,753
EBIT
-21,819
-25,238
-24,669
-17,205
Net Income
-21,819
-23,516
-24,669
-16,527
Net Change In Cash
0
0
0
0
Cost of Revenue
-50,173
Free Cash Flow
-16,875
-18,891
-15,734
-12,213
Cash
1,754
3,620
4,555
54,727
Basic Shares
17,142
12,301
11,230
8,679

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$0.33
2025-03-31
-$0.22
2024-12-31
-$0.30